3 D/L Capital Management, LLC Pfizer Inc Transaction History

3 D/L Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	BUY	$32.09 - $37.51 $24,035 - $28,094	749 Added 6.97%	11,490 $381,000
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $36 - $41	1 Added 0.01%	10,741 $393,000
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $8,468 - $11,025	215 Added 2.04%	10,740 $438,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $11,439 - $14,933	274 Added 2.67%	10,525 $539,000
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $343,305 - $387,180	10,251 New	10,251 $371,000

3,271

3.63B

74.3M

107M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of 3 D/L Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 3 D/L Capital Management, LLC with notifications on news.